Akari Therapeutics Plc

Nasdaq:AKTX

Pharmaceutical Preparations·TAMPA, FL

CEO

Gaslightwala Abizer

CFO

Farag Kameel D.

Financials

14 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	4/15/25	→
10-Q	Q3 2024	9/30/24	11/19/24	→
10-Q	Q2 2024	6/30/24	8/19/24	→
↓

Earnings Releases (8-K)

5 shown

Filed	Period
5/15/25	Q2 FY2025	→
4/16/25	Q1 FY2025	→
8/19/24	Q3 FY2024	→
5/16/24	Q2 FY2024	→
4/1/24	Q1 FY2024	→

News (8-K)

53 shown

Filed	Type	Description
3/2/26	Vote	Submission of Matters to a Vote of Security Holders	→
12/17/25	Agreement	Entry into a Material Definitive Agreement	→
12/16/25	Vote	Submission of Matters to a Vote of Security Holders	→
12/8/25	Reg FD	Regulation FD Disclosure	→
11/26/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
10/23/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/23/26	S-1	S-1	→
12/17/25	424B5	424B5	→
12/5/25	424B3	424B3	→
11/17/25	S-1	S-1	→
10/16/25	424B5	424B5	→
8/29/25	S-1	S-1	→
↓

Filing History(694 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13D/A

Mar 4, 2026

0001493152-26-008880

—

15.3 KB

SCHEDULE 13D/A

Mar 4, 2026

0001493152-26-008874

—

10.4 KB

SCHEDULE 13G/A

Mar 4, 2026

0001493152-26-008873

—

7.2 KB

8-K

Mar 2, 2026

0001493152-26-0085708-K

Mar 2, 2026

250.4 KB

DEF 14A

Feb 2, 2026

0001493152-26-004754DEF 14A

Feb 2, 2026

4.2 MB

EFFECT

Jan 29, 2026

9999999995-26-000356

—

1.9 KB

S-1

Jan 23, 2026

0001493152-26-003458S-1

—

29.7 MB

PRE 14A

Jan 22, 2026

0001493152-26-003252PRE 14A

Jan 22, 2026

4.1 MB

Dec 18, 2025

0001493152-25-0284224

Dec 16, 2025

25.2 KB

Dec 18, 2025

0001493152-25-0284214

Dec 16, 2025

24.9 KB

Dec 18, 2025

0001493152-25-0284204

Dec 16, 2025

23.7 KB

Dec 18, 2025

0001493152-25-0284194

Dec 16, 2025

9.0 KB

Dec 18, 2025

0001493152-25-0284184

Dec 16, 2025

25.1 KB

Dec 18, 2025

0001493152-25-0284174

Dec 16, 2025

14.5 KB

Dec 18, 2025

0001493152-25-0284164

Dec 16, 2025

24.0 KB

8-K

Dec 17, 2025

0001493152-25-0280758-K

Dec 16, 2025

2.0 MB

424B5

Dec 17, 2025

0001493152-25-028073424B5

—

754.3 KB

8-K

Dec 16, 2025

0001493152-25-0279698-K

Dec 15, 2025

267.8 KB

8-K

Dec 8, 2025

0001493152-25-0265338-K

Dec 8, 2025

4.7 MB

424B3

Dec 5, 2025

0001493152-25-026387424B3

—

392.2 KB

EFFECT

Dec 2, 2025

9999999995-25-003483

—

1.9 KB

8-K

Nov 26, 2025

0001493152-25-0251778-K

Nov 24, 2025

248.3 KB

DEF 14A

Nov 17, 2025

0001493152-25-023911DEF 14A

Nov 17, 2025

1.6 MB

S-1

Nov 17, 2025

0001493152-25-023908S-1

—

812.9 KB

10-Q

Nov 13, 2025

0001493152-25-02239010-Q

Sep 30, 2025

8.6 MB

25 filings shown

Akari Therapeutics Plc

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(694 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/2/26	DEF 14A	DEF 14A	→
1/22/26	PRE 14A	PRE 14A	→
11/17/25	DEF 14A	DEF 14A	→
11/7/25	PRE 14A	PRE 14A	→
6/6/25	DEF 14A	DEF 14A	→
5/23/25	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
12/18/25	4	4	→
12/18/25	4	4	→
12/18/25	4	4	→
12/18/25	4	4	→
12/18/25	4	4	→
12/18/25	4	4	→
↓

Filed	Form	Description
3/4/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
3/4/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
3/4/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/29/26	EFFECT	EFFECT	→
12/2/25	EFFECT	EFFECT	→
10/24/25	D	D	→
↓